drugset / Trial / NCT02043366

Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients

NCT02043366

RandomizedParallel-groupDouble-blindPrevention

Summary

Purpose: To explore and compare antihyperalgesic effects of butorphanol, flurbiprofen axetil, and a combination of both received before anesthesia induction. To evaluate and examine the incidence of adverse effects with the purpose of selecting the optimum dose. .

Timeline

Start
2014-02
Primary completion
2015-06
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Butorphanol Other / unclassified 10 ug/kg Intravenous
Comparator Butorphanol Other / unclassified 20 ug/kg Intravenous
Comparator Remifentanil Small molecule 0.3 ug/kg Intravenous
Comparator Sufentanil Other / unclassified 0.3 ug/kg Intravenous
Comparator flurbiprofen axetil Other / unclassified 0.5 mg/kg Intravenous
Comparator flurbiprofen axetil Other / unclassified 1 mg/kg Intravenous

Indications

No indication recorded.